Technical Analysis for GRTS - Gritstone Oncology, Inc.

Grade Last Price % Change Price Change
F 0.03 -31.78% -0.02
GRTS closed down 31.78 percent on Monday, October 21, 2024, on 2.65 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Nov 6
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -31.78%
Calm After Storm Range Contraction -31.78%
NR7 Range Contraction -31.78%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight multiple cancer types. The company has built its tumor-specific immunotherapy approach on two key pillars—first, a proprietary machine learning-based platform, Gritstone EDGE™, which provides a powerful ability to predict from a routine tumor biopsy the tumor-specific neoantigens, or TSNA, that are presented on a patient’s tumor cells; and second, the ability to develop and manufacture potent immunotherapies utilizing patients’ TSNA to drive the patient’s immune system to attack and destroy tumors.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Immune System Immunotherapy Oncology Tumor Cancer Immunotherapy Machine Learning Immunotherapies Virotherapy Biopsy Tumor Cell

Is GRTS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.17
52 Week Low 0.031
Average Volume 21,017,655
200-Day Moving Average 1.17
50-Day Moving Average 0.40
20-Day Moving Average 0.24
10-Day Moving Average 0.08
Average True Range 0.04
RSI (14) 18.70
ADX 42.17
+DI 14.78
-DI 48.63
Chandelier Exit (Long, 3 ATRs) 0.53
Chandelier Exit (Short, 3 ATRs) 0.16
Upper Bollinger Bands 0.67
Lower Bollinger Band -0.19
Percent B (%b) 0.26
BandWidth 357.60
MACD Line -0.12
MACD Signal Line -0.11
MACD Histogram -0.0126
Fundamentals Value
Market Cap 3.07 Million
Num Shares 95.3 Million
EPS -1.24
Price-to-Earnings (P/E) Ratio -0.03
Price-to-Sales 20.98
Price-to-Book 2.90
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.05
Resistance 3 (R3) 0.05 0.04 0.04
Resistance 2 (R2) 0.04 0.04 0.04 0.04
Resistance 1 (R1) 0.04 0.04 0.04 0.04 0.04
Pivot Point 0.03 0.03 0.03 0.03 0.03
Support 1 (S1) 0.03 0.03 0.03 0.03 0.02
Support 2 (S2) 0.03 0.03 0.02 0.02
Support 3 (S3) 0.02 0.03 0.02
Support 4 (S4) 0.02